Product correctly added to cart.

discount label
Cladribine Impurity D
View 3D

Biosynth logo

Cladribine Impurity D

CAS: 5542-92-7

Ref. 3D-IC179959

1mg
248.00 €
2mg
364.00 €
5mg
517.00 €
10mg
801.00 €
25mg
1,160.00 €
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
Cladribine Impurity D
Description:

Cladribine Impurity D is a polymerase chain reaction (PCR) diagnostic agent that is used to identify the presence of Cladribine in the blood. Cladribine Impurity D binds to an RNA polymerase enzyme, which prevents it from synthesizing DNA and RNA, resulting in a lack of cell proliferation. This drug has been shown to be effective in treating bowel disease and solid tumours. It also has a number of side effects including interactions with other medications, such as natural compounds and autoimmune diseases, as well as bronchiolitis obliterans and lymphoma. Cladribine Impurity D also interacts with the IL-2 receptor on cells, which may cause allergic reactions. The MDA-MB-231 breast cancer cells are resistant to this drug due to their expression of the protein MCL-1.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
285.69 g/mol
Formula:
C10H12ClN5O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IC179959 Cladribine Impurity D

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".